Drreddys Laboratories | RDY - Current Assets


Drreddys Laboratories reported INR3.31B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Cipla INR 249.18B 16.3B Sep/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Drreddys Laboratories INR 3.31B 164.26M Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Richter Gedeon HUF 772.16B 39.24B Dec/2025
Sun Pharmaceuticals INR 601.36B 75.42B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025